Merrimack Pharmaceuticals
MACK
#8378
Rank
โ‚น20.20 B
Marketcap
โ‚น1,367
Share price
0.00%
Change (1 day)
9.33%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): โ‚น1,156

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น1,252. In 2016 the company made an earnings per share (EPS) of -โ‚น1,105 an increase over its 2015 EPS that were of -โ‚น1,192.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)โ‚น1,156
2016-โ‚น1,105-7.35%
2015-โ‚น1,19265%
2014-โ‚น722.58-39.39%
2013-โ‚น1,192-54.01%
2012-โ‚น2,592

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น334.71-73.26%๐Ÿ‡ซ๐Ÿ‡ท France
AVEO Oncology
AVEO
-โ‚น75.87-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.84-100.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-โ‚น170.71-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น6,929-653.46%๐Ÿ‡บ๐Ÿ‡ธ USA